Lapides Asset Management, LLC - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 48 filers reported holding TRINITY BIOTECH PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Lapides Asset Management, LLC ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q2 2019$1,082,000
-42.1%
655,500
-0.0%
0.50%
-29.2%
Q1 2019$1,868,000
+27.1%
655,600
+2.1%
0.70%
+18.3%
Q4 2018$1,470,000
-68.6%
641,900
-45.2%
0.60%
-41.8%
Q3 2018$4,688,000
-24.1%
1,172,100
-5.1%
1.02%
-22.0%
Q2 2018$6,176,000
-1.0%
1,235,300
+1.9%
1.31%
-4.1%
Q1 2018$6,241,000
+4.3%
1,211,900
+3.3%
1.37%
+5.5%
Q4 2017$5,984,000
-17.3%
1,173,400
-9.0%
1.30%
-12.4%
Q3 2017$7,235,000
-6.5%
1,289,6000.0%1.48%
-0.9%
Q2 2017$7,738,000
+1.1%
1,289,600
+0.4%
1.50%
+4.3%
Q1 2017$7,653,000
-5.4%
1,284,100
+9.9%
1.44%
-1.2%
Q4 2016$8,088,000
-13.1%
1,168,800
+66.1%
1.45%
-8.3%
Q3 2016$9,302,000
+16.3%
703,600
-0.2%
1.58%
+7.2%
Q2 2016$7,996,000
-2.7%
705,1000.0%1.48%
+0.8%
Q1 2016$8,221,000
+26.1%
705,100
+27.2%
1.47%
+28.5%
Q4 2015$6,519,000
+54.2%
554,300
+50.0%
1.14%
+56.9%
Q3 2015$4,227,000
-22.5%
369,500
+22.4%
0.73%
-16.1%
Q2 2015$5,451,000
+62.7%
301,800
+73.3%
0.87%
+55.9%
Q1 2015$3,351,000
-17.6%
174,100
-25.1%
0.56%
+1.1%
Q4 2014$4,069,000232,4000.55%
Other shareholders
TRINITY BIOTECH PLC shareholders Q4 2017
NameSharesValueWeighting ↓
ACK Asset Management 672,100$14,625,0005.62%
GOLDMAN CAPITAL MANAGEMENT INC 312,000$6,789,0004.48%
Lyon Street Capital, LLC 407,586$8,870,047,0004.37%
GREAT POINT PARTNERS LLC 189,071$4,114,0002.85%
Adirondack Research & Management Inc. 161,507$3,514,0002.02%
Park West Asset Management LLC 483,355$10,518,0001.56%
Benchmark Capital Advisors 56,954$1,239,0000.89%
WOODMONT INVESTMENT COUNSEL LLC 76,607$1,667,0000.61%
SHEPHERD KAPLAN KROCHUK, LLC 156,000$3,394,0000.55%
HEARTLAND ADVISORS INC 1,250,364$27,208,0000.50%
View complete list of TRINITY BIOTECH PLC shareholders